Modifier genetics in zebrafish identify Chk1 and an associated survival pathway as targets for pharmacotherapy of MDS/AML with P53 mutations.

Samuel Sidi; Andreas T. Hagen; Richard Kennedy; Shintaro Imamura; Shuji Kishi; John Kanki; Alan D'Andrea; A. Thomas Look

Modifier genetics in zebrafish identify Chk1 and an associated survival pathway as targets for pharmacotherapy of MDS/AML with P53 mutations.

Samuel Sidi, Andreas T. Hagen, Richard Kennedy, Shintaro Imamura, Shuji Kishi, John Kanki, Alan D'Andrea, A. Thomas Look

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	416A-416A
Number of pages	1
Journal	Blood
Volume	108
Issue number	11
Publication status	Published - 16 Nov 2006
Event	48th Annual Meeting of the American-Society-of-Hematology - Orlando, United States Duration: 09 Dec 2006 → 12 Dec 2006

Cite this

@article{076a3b02535449a88510ab51764da4f7,

title = "Modifier genetics in zebrafish identify Chk1 and an associated survival pathway as targets for pharmacotherapy of MDS/AML with P53 mutations.",

author = "Samuel Sidi and Hagen, {Andreas T.} and Richard Kennedy and Shintaro Imamura and Shuji Kishi and John Kanki and Alan D'Andrea and Look, {A. Thomas}",

year = "2006",

month = nov,

day = "16",

language = "English",

volume = "108",

pages = "416A--416A",

journal = "Blood",

issn = "0006-4971",

publisher = "AMER SOC HEMATOLOGY",

number = "11",

note = "48th Annual Meeting of the American-Society-of-Hematology ; Conference date: 09-12-2006 Through 12-12-2006",

}

Modifier genetics in zebrafish identify Chk1 and an associated survival pathway as targets for pharmacotherapy of MDS/AML with P53 mutations. / Sidi, Samuel; Hagen, Andreas T.; Kennedy, Richard; Imamura, Shintaro; Kishi, Shuji; Kanki, John; D'Andrea, Alan; Look, A. Thomas.

In: Blood, Vol. 108, No. 11, 16.11.2006, p. 416A-416A.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Modifier genetics in zebrafish identify Chk1 and an associated survival pathway as targets for pharmacotherapy of MDS/AML with P53 mutations.

AU - Sidi, Samuel

AU - Hagen, Andreas T.

AU - Kennedy, Richard

AU - Imamura, Shintaro

AU - Kishi, Shuji

AU - Kanki, John

AU - D'Andrea, Alan

AU - Look, A. Thomas

PY - 2006/11/16

Y1 - 2006/11/16

M3 - Meeting abstract

VL - 108

SP - 416A-416A

JO - Blood

JF - Blood

SN - 0006-4971

IS - 11

T2 - 48th Annual Meeting of the American-Society-of-Hematology

Y2 - 9 December 2006 through 12 December 2006

ER -